221 related articles for article (PubMed ID: 33569624)
1. Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.
Schurink NW; van Kranen SR; Berbee M; van Elmpt W; Bakers FCH; Roberti S; van Griethuysen JJM; Min LA; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2021 Sep; 31(9):7031-7038. PubMed ID: 33569624
[TBL] [Abstract][Full Text] [Related]
2. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.
Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488
[TBL] [Abstract][Full Text] [Related]
3. Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study.
Vuijk FA; Feshtali Shahbazi S; Noortman WA; van Velden FHP; Dibbets-Schneider P; Marinelli AWKS; Neijenhuis PA; Schmitz R; Ghariq E; Velema LA; Peters FP; Smit F; Peeters KCMJ; Temmink SJD; Crobach SALP; Putter H; Vahrmeijer AL; Hilling DE; de Geus-Oei LF
Nucl Med Commun; 2023 Jul; 44(7):613-621. PubMed ID: 37132268
[TBL] [Abstract][Full Text] [Related]
4. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
[TBL] [Abstract][Full Text] [Related]
5. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M
Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
[TBL] [Abstract][Full Text] [Related]
7. Predicting locally advanced rectal cancer response to neoadjuvant therapy with
Giannini V; Mazzetti S; Bertotto I; Chiarenza C; Cauda S; Delmastro E; Bracco C; Di Dia A; Leone F; Medico E; Pisacane A; Ribero D; Stasi M; Regge D
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):878-888. PubMed ID: 30637502
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.
Lovinfosse P; Polus M; Van Daele D; Martinive P; Daenen F; Hatt M; Visvikis D; Koopmansch B; Lambert F; Coimbra C; Seidel L; Albert A; Delvenne P; Hustinx R
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):365-375. PubMed ID: 29046927
[TBL] [Abstract][Full Text] [Related]
9.
Avallone A; Aloj L; Pecori B; Caracò C; De Stefano A; Tatangelo F; Silvestro L; Granata V; Bianco F; Romano C; Di Gennaro F; Budillon A; Petrillo A; Muto P; Botti G; Delrio P; Lastoria S
J Nucl Med; 2019 Nov; 60(11):1560-1568. PubMed ID: 30877175
[TBL] [Abstract][Full Text] [Related]
10. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
[TBL] [Abstract][Full Text] [Related]
11. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
Park H; Kim KA; Jung JH; Rhie J; Choi SY
Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317
[TBL] [Abstract][Full Text] [Related]
12. Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer.
Herold A; Wassipaul C; Weber M; Lindenlaub F; Rasul S; Stift A; Stift J; Mayerhoefer ME; Hacker M; Ba-Ssalamah A; Haug AR; Tamandl D
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):205-217. PubMed ID: 36063201
[TBL] [Abstract][Full Text] [Related]
13. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
14. Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.
Trada Y; Keall P; Jameson M; Moses D; Lin P; Chlap P; Holloway L; Min M; Forstner D; Fowler A; Lee MT
Eur Radiol; 2023 Dec; 33(12):8788-8799. PubMed ID: 37405500
[TBL] [Abstract][Full Text] [Related]
15. Response of locally advanced rectal cancer (LARC) to radiochemotherapy: DW-MRI and multiparametric PET/CT in correlation with histopathology.
Cerny M; Dunet V; Rebecchini C; Hahnloser D; Prior J; Sempoux C; Schmidt S
Nuklearmedizin; 2019 Feb; 58(1):28-38. PubMed ID: 30769371
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
17. Prognostic utility of serial
Fernando S; Lin M; Pham TT; Chong S; Ip E; Wong K; Chua W; Ng W; Lin P; Lim S
Br J Radiol; 2020 Jan; 93(1105):20190455. PubMed ID: 31617737
[TBL] [Abstract][Full Text] [Related]
18. Prediction of outcome using pretreatment
Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
[TBL] [Abstract][Full Text] [Related]
19. Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer.
Karahan Şen NP; Aksu A; Kaya GÇ
Ann Nucl Med; 2020 Dec; 34(12):960-967. PubMed ID: 32951129
[TBL] [Abstract][Full Text] [Related]
20. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
